Iovance Biotherapeutics, Inc. Common Stock (IOVA) is a publicly traded Healthcare sector company. As of November 3, 2026, IOVA trades at $8.62 with a market cap of $3.84B and a P/E ratio of -7.04. IOVA moved +7.11% today. Year to date, IOVA is +217.70%; over the trailing twelve months it is +306.40%. Its 52-week range spans $1.64 to $15.37. Analyst consensus is strong buy with an average price target of $14.20. Rallies surfaces IOVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for IOVA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $8.62 |
| Market Cap | $3.84B |
| P/E Ratio | -7.04 |
| EPS | $-1.89 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.37 |
| 52-Week Low | $1.64 |
| Volume | 5.90M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.19M |
| Net Income | $-444.04M |
| Gross Margin | -804.54% |
10 analysts cover IOVA: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $14.20.